SimonAlexanderMallalMD

PubMed

• 124 citations
  T cells specific for α-myosin drive immunotherapy-related myocarditis.
  Margaret L Axelrod, Wouter C Meijers, Elles M Screever, Juan Qin, Mary Grace Carroll
  Nature. 2022-11-01
• 118 citations
  A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis
  Douglas B. Johnson, Wyatt J. McDonnell, Paula I. Gonzalez-Ericsson, Rami N. Al-Rohil, Bret C. Mobley
  Nature Medicine. 2019-07-22
• 266 citations
  Influence of HLA-C Expression Level on HIV Control
  Richard Apps, Ying Qi, Jonathan M. Carlson, Haoyan Chen, Xiaojiang Gao
  Science. 2013-04-05

Journal Articles

• High CD8 T Cell Receptor Clonality and Altered CDR3 Properties Are Associated with Elevated Isolevuglandins in Adipose Tissue During Diet-Induced Obesity  
  Simon Mallal, MD, Diabetes Care
• Short Population Report Sequence-Based HLA-A, B, C, DP, DQ, and DR Typing of 714 Adults from Colombo, Sri Lanka  
  Simon Mallal, MD, ScienceDirect
• Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection, in magnitude, HLA restriction and antigen specificity  
  Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, Peters B, de Silva AD, Phillips E, Mallal S, Diehl SA, Kirkpatrick BD, Whitehead SS, Durbin AP, Sette A, Weiskopf D, J Virol, 1/14/2016
• RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immu...  
  Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sanchez V, Sanders M, Cook RS, Wang K, Miller VA, Stephens P..., Clin Cancer Res, 1/1/2016
• Prostaglandin I2 Signaling and Inhibition of Group 2 Innate Lymphoid Cell Responses  
  Zhou W, Toki S, Zhang J, Goleniewska K, Newcomb DC, Cephus JY, Dulek DE, Bloodworth MT, Stier MT, Polosuhkin V, Gangula RD, Mallal SA, Broide DH, Peebles RSJ, American Journal of Respiratory and Critical Care Medicine, 1/1/2016
• Extensive CD4 and CD8 T Cell Cross-Reactivity between Alphaherpesviruses  
  Jing L, Laing KJ, Dong L, Russell RM, Barlow RS, Haas JG, Ramchandani MS, Johnston C, Buus S, Redwood AJ, White KD, Mallal SA, Phillips EJ, Posavad CM, Wald A, Koelle DM, Journal of Immunology, 1/1/2016
• Impact of Pre-adapted HIV Transmission  
  Carlson JM, Du VY, Pfeifer N, Bansal A, Tan VYF, Power K, Brumme CJ, Kreimer A, DeZiel CE, Fusi N, Schaefer M, Brockman MA, Gilmour J, Price MA, Kilembe W, Haubrich R,..., Nature Medicine, 1/1/2016
• CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli  
  Harrison DG, Itani HA, Xiao L, Saleh MAA, Wu J, Pilkinton MA, Dale BL, Rbarbaro N, Foss JD, Kirabo A, Montaniel KRC, Norlander AE, Chen W, Sato, R, Navar LG, Mallal S..., Circulation Research, 1/1/2016
• HIV-1 Mutation and Recombination Rates Are Different in Microphages and T-Cells  
  Cromer D, Schlub TE, Smyth RP, Grimm AJ, Chopra A, Mallal S, Davenport MP, Mak J, Viruses, 1/1/2016
• HLA DRB1 alleles are associated with different response magnitudes of dengue virus specific CD4+ T cell responses  
  Weiskopf D, Angelo MA, Grifoni A, O'Rourke PH, Sidney J, Paul S, De Silva AD, Phillips E, Mallal S, Premawansa S, Premawansa G, et al, J Infect Dis, 1/1/2016
• Allergic Mechanisms: Characterizing immune responses in severe T-cell mediated adverse drug reaction  
  Konvinse KC, White K, Pavlos R, Redwood A, Trubiano J, Ergen E, Mallal SA, Phillips EJ., J Immunol, 2016
• Abacavir-reactive memory T cells are present in drug naïve individuals  
  Lucas A, Lucas M, Strhyn A, Keane NM, McKinnon E Pavlos R, Moran EM, Meyer-Pannwitt V, Gaudieri S, D'Orsogna L, Kalams S, Ostrov DA, Buus S, Peters B, Mallal S, Philli..., PlosOne, 1/1/2015
• Acyclovir has low but detectable influence on HLA-B*57:01 specificity without inducing hypersensitivity  
  Metushi I, Wriston A, Banerjee P, Gohlke B, English A, Lucas A, Moore C, Sidney J, Buus S, Ostrov D, Mallal S, Phillips E, Shabanowitz J, Hunt D, Preissner R, Peters B, PlosOne, 1/1/2015
• Evolving models of the immunopathogenesis of T-cell mediated drug allergy: The role of host, pathogens, and drug response  
  White K, Chung W-H, Hung S-I, Mallal S, Phillips E, J Allergy Clin Immunol: In Practice, 1/1/2015
• Anti-Hepatitis C virus T-cell immunity in the context of multiple exposures to the virus  
  Pfaffarott K, Deshpande P, McKinnon E, Merani S, Lucas A, Heckerman D, Mallal S, John M, Gaudieri S, Lucas M, PlosOne, 1/1/2015
• Report from the National Institute of Allergy and Infectious Disease Workshop on Drug Allergy  
  Wheatley L, Plaut M, Schwaninger J, Banergi M, Castells M, Finkelman F, Gleich G, Guttman-Yassky E, Mallal S, Maisbitt D, Ostrov D, Phillips E, Pichler W, Platts-Mills..., J Allergy Clin Immunol, 1/1/2015
• Helicobacter pylori adaptation in vivo in response to a high salt diet (IAI00918-15R1)  
  Loh L, Gaddy J, Algood H, Gaudieri S, Mallal S, Cover T, Infection and Immunity, 1/1/2015
• The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy  
  Hemler JA, Phillips EJ, Mallal SA, Kendall PL, Ann Allergy Asthma Immunol, 1/1/2015
• Identifying recombination hotspots in the HIV-1 genome  
  Smyth RP, Schlub TE, Grimm AJ, Waugh C, Ellenberg P, Chopra A, Mallal S, Cromer D, Mak J, Davenport MP, Journal of Virology, 1/1/2014
• Fever, Rash, and Systemic Symptoms: Understanding the Role of Virus and HLA in Severe Cutaneous Drug Allergy  
  Pavlos R, Mallal S, Ostrov D, Pompeu Y, Phillips E, The Journal of Allergy and Clinical Immunology: In Practice, 1/1/2014
• Fifteen to twenty percent of HIV substitution mutations are associated with recombination  
  Schlub TE, Grimm AJ, Smyth RP, Cromer D, Chopra A, Mallal S, Venturi V, Waugh C, Mak J, Davenport MP, Journal of Virology, 1/1/2014
• Differential escape patterns within the dominant HLA-b*57:03-restricted HIV gag epitope reflect distinct clade-specific functional constraints  
  Payne R, Branch S, Kloverpris H, Matthews P, Koofhethile C, Strong T, Adland E, Leitman E, Frater AJ, Ndung'u T, Hunter E, Haubrich R, Mothe B, Edwards A, Riddell L, C..., Journal of Virology, 1/1/2014
• Host-specific adaptation of HIV-1 subtype B in the Japanese population  
  Chikata T, Carlson J, Tamura Y, Borghan M, Naruto T, Hashimoto M, Murakoshi H, Le A, Mallal S, John M, Gatanaga H, Oka S, Brumme Z, and Takiguchi M, Journal of Virology, 1/1/2014
• Transmitted Escape Mutations Lead to Accelerated HIV-1 Disease Progression and Largely Define the Relative Contribution of HLA Alleles to Control  
  Carlson JM, Schaefer M, Brumme C, Pfeifer N, Shapiro R, Ndung'u T, Frater J, Mallal S, John M, Heckerman D, Goulder P, Brumme Z, Hunter E., AIDS Res Hum Retroviruses, 2014
• HLA Class I-drug-T-cell receptor interactions in SJS/TEN  
  Rive C, Pavlos R, Ostrov D, Plascencia P, Hung SH, Chung WH, Peters P, Buus S, Mallal S, Phillips EJ., Clinical and Translational Allergy, 2014
• Join now to see all

Books/Book Chapters

• Human Vaccines: Emerging Technologies in Design and Development 
  Chapter: Immunogenetics and Vaccination 
  Page 113 - 133John M, Gaudieri S, Mallal SEditors: Koff W, Modjarrad K.Elsevier Science2016
• On Human Nature: Evolution, Diversity, Psychology, Ethics, Politics and Religion 
  Chapter: What HIV has taught about the interactions between biology, culture and other evolving systems 
  Page 771 - 776Mallal SEditors: Tibayrene M, Ayala FJ.Academic PressEdition 1st,2016
• Clinical Genomics: Practical Application in Adult Patient Care 
  Chapter: Abacavir Pharmacogenomics 
  Page 45 - 48Mallal S & Phillips EEditors: Murray M, Babyatsky M, Giovanni M, Alkuraya F, & Stewart D.McGraw Hill2013
• Pharmacogenomic Testing in Current Clinical Practice 
  Chapter: Abacavir 
  Page 201 - 212Phillips E, Mallal SEditors: Wu A, Yeo K.Humana Press, New York, NY2011
• The HLA Complex in Biology and Medicine: A Resource Book 
  Chapter: HLA and Drug Reactions 
  Page 536 - 565Phillips E, Mallal SEditors: Mehra NK.Japee Brothers Medical Publishers Pty Ltd, New Delhi, India2010
• AIDS Therapy 
  Chapter: Lactic acidosis and other mitochondrial disorders associated with HIV therapy 
  Page 1299 - 1310Nolan D, Mallal SEditors: Saag M, Dolin R, Masur H.Elsevier, Inc., USAEdition 3rd,2007
• Drug Hypersensitivity 
  Chapter: Abacavir hypersensitivity 
  Page 116 - 125Nolan D, Almeida C, Phillips E, Mallal SEditors: Pichler W.Karger, Basel, Switzerland2007
• Textbook on Nutrition and AIDS 
  Chapter: Antiretroviral therapy-associated lipodystrophy: Clinical aspects and current concepts in pathogenesis 
  Page 404 - 451Nolan D, John M, Martinez OP, Mallal SEditors: Polo Rodriquez R.NILO Industria Grafica, SpainEdition 3rd,2002
• Manuel de Nutricion y SIDA 
  Chapter: Pathogenesis of Body Fat Redistribution and Metabolic Alterations 
  Page 436 - 493Martinez OP, John M, Nolan D, Mallal SAEditors: Polo Rodriguez R.NILO Industria Grafica, SpainEdition 3rd,2002
• Monograph: Long-term complications associated with HIV therapy: A year in review 
  Editors: S Mallal.2002
• AIDS Lipodystrophy Pathophysiological Basis and Clinical Management 
  Chapter: Lipodystrophy syndrome in the Western Australian Cohort 
  Page 28 - 35John M, Nolan D, Mallal SAEditors: Jager H, Mauss S.Thieme Verlag Pty Ltd, Stuttgart, Germany2001
• Monograph: Immune Restoration Diseases in HIV Patients: A Case Study Review. HCV-related hepatitis and inflamed molluscum contagiosum after HAART 
  Chapter: HCV-related hepatitis and inflamed molluscum contagiosum after HAART 
  Page 23 - 25John M, French MAH, Mallal SAAdis International Press1999
• Monograph: Immune Restoration Diseases in HIV Patients: A Case Study Review. HCV-related hepatitis and inflamed molluscum contagiosum after HAART 
  Chapter: Toxoplasma-related focal encephalitis and shingles after HAART 
  Page 36 - 37John M, Mallal SAAdis International Press1999
• Monograph: Immune Restoration Diseases in HIV Patients: A Case Study Review 
  Chapter: Bartonella henselae-related sporotrichoid lymphangitis and lymphadenitis after dual nucleoside analogue therapy 
  Page 20 - 22Martinez OP, Mallal SA, Anstey NAdis International Press1999
• HLA 
  Chapter: Central MHC genes between HLA B and complement C4 confer risks for HIV 1 disease progression 
  Page 544 - 547Cameron PU, Mallal SA, French MA, Dawkins RLEditors: Tsuji K, Aizawa M, Sasazuki T.Oxford University Press, New York, NY1991
• Join now to see all

Abstracts/Posters

• Characterization of TCR repertoire diversity and tissue distribution of drug-specific T cells in DRESS
  White KD, Konvinse K, Pilkinton M, Barnett L, Gangula R, Redwood A, Pavlos R, Chopra A, Mallal S, Phillips E, 16th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, MA, 1/22/2016
• Specific Binding Characteristics Of HLA Alleles Associated With Nevirapine Hypersensitivity
  Pavlos R, McKinnon E, Ostrov D, Peters B, Buus S, Koelle D, Chopra A, Rive C, Redwood A, Restrepo S, Bracey A, Yuan J, Gaudieri S, Carrington M, Haas D, Mallal S, Phil..., 7th Drug Hypersensitivity Meeting, Malaga, Spain, 1/21/2016
• Variation in ERAP influences risk for HLA-B*57:01 abacavir hypersensitivity
  Pavlos R, Strautins K, James I, Mallal S, Redwood A, Phillips E, 23rd Conference on Retroviruses and Opportunistic Infections (CROI); 7th Drug Hypersensitivity Meeting, Boston, MA, 2015; Malaga, Spain, 2016, 1/21/2016
• A Snapshot of Neuropsychological Health in "50-Something Aged" People Living with Chronic HIV Infection
  Herrmann SE, McKinnon E, Skinner MJ, Grace A, Locke V, Correia H, Byrnes M, Chaney R, Mastaglia FL, Mallal S, 26th Australasian HIV AIDS Conference, Adelaide, Southern Australia, Australia, 1/16/2016
• Isolation of activated CD8+ T cells following drug stimulation: a first step toward evaluating the heterologous immunity model for pure T-cell mediated adverse drug re...
  White K, Redwood A, Jing L, Konvinse K, Pavlos R, Koelle D, Mallal S, Phillips E, ASCI, Chicago, IL, 1/15/2016
• Characterizing immune responses in severe T-cell mediated adverse drug reaction
  Konvinse KC, White K, Pavlos R, Redwood A, Trubiano J, Ergen E, Mallal SA, Phillips EJ, American Association of Immunologists Conference, (AAI), Seattle, WA, 1/13/2016
• HIV-1 residues under strong functional constraint are predicted by measures of evolutionary rather than population-level genetic conservation
  John M, Gaudieri S, Chopra A, Leary S, Jorritsma J, Mallal S, Baraki B, Brockman M, Brumme ZL, 25th Conference of the Canadian Association for HIV Research (CAHR), Winnipeg, Manitoba, Canada, 1/12/2016
• Cutting Edge Tools for Phenotyping and Characterising T-Cell Subsets
  Chopra A, Gaudieri S, Clark H, Blinco J, Cooper D, Leary S, Watson M, Mallal S, Science on the Swan, Perth, Western Australia, 1/2/2016
• Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity
  Redwood A, Strautins K, White K, Chopra A, Konvinse K, Leary S, Pavlos R, Mallal S, Phillips E, 23rd Conference on Retroviruses and Opportunistic Infections (CROI); 7th Drug Hypersensitivity Meeting; Science on the Swan, Boston, MA, 2015; Malaga, Spain, 2016; Perth, Western Australia, 2016, 1/2/2016
• Identifying Sites of “Deep Conservation" in HIV-1 for Vaccine Immunogen Design
  Gaudieri S, Chopra A, Leary S, Clark H, Mallal S, Baraki B, Brockman MA, Brumme ZL, John M, Science on the Swan, Perth, Western Australia, 1/2/2016
• Analysis and Visualization tools for NGS sequence data
  Leary S, Cooper D, Chopra A, Watson M, Mallal S, Science on the Swan, Perth, Western Australia, 1/2/2016
• Integration Site Analysis of Latently Infected Cell Lines: Evidence of Ongoing Replication
  Chopra A, Symons J, Leary S, Cooper D, Blinco J, Malantinkova E, Spiegelaerde W Vandekerckhove L, Lewin SR, Cameron P, Mallal S, Science on the Swan, Perth, Western Australia, 1/2/2016
• Mapping T-cell responses in patients with SJS/TEN
  Redwood A, Jing L. Strautins K, Pavlos R, Chopra A, Tran T, White K, Leary S, Mallal S, Phillips E, SJS/TEN: Building Multidisciplinary Network to Drive Science & Translation, Orlando, FL, 1/2/2016
• Identification of Clonal TCR Expansion Using Next Generation Sequencing
  Chopra A, Clark H, Blinco J, John M, Watson M, Mallal S, Science on the Swan, Perth, Western Australia, 1/21/2015
• Ultra-deep Sequencing Reveals Dynamics of Drug Resistance-Associated Variants in Hepatitis C Viruses: Relevance to Treatment Outcome and Resistance Screening
  Barnard R, Chopra A, James I, Cooper D, Blinco J, Watson M, Jabara C, Lemon S, Mallal S, Gaudieri S, Science on the Swan, Perth, Western Australia, 1/21/2015
• Hybridization Based Enrichment for Genotyping HLA and KIR Genes using Next Generation Sequencing
  Cooper D, Chopra A, Blinco J, Leary S, Watson M, Mallal S, Science on the Swan, Perth, Western Australia, 1/21/2015
• In search of a virotope: Identification of herpesvirus specific CD8 T cells
  Redwood A, Jing L, Tran T, White K, Mallal S, Koelle D, Phillips E, Science on the Swan, Perth, Western Australia, 1/21/2015
• Specific Binding Characteristics of HLA Alleles Associate with Nevirapine Hypersensitivity
  Pavlos R, Rive C, McKinnon E, Ostrov D, Plascensia PC, Peters B, Yuan J, Gaudieri S, Haas D, Mallal S, Phillips EJ, Science on the Swan, Perth, Western Australia, 1/21/2015
• Personalizing Immunology: The Immunopathogenesis of Severe T-cell Mediated Drug Hypersensitivity
  Mallal S, Phillips E, Advances in Personalized Medicine Workshop, Institute for Immunology & Infectious Diseases, Murdoch University, Perth, Western Australia, 1/20/2015
• Integration Analysis of Latently Infected Cell Lines: Evidence of Ongoing Replication
  Symons J, Chopra A, Malantinkova E, Spiegelaerde W, Leary S, Cooper D, Vanderckhove L, Mallal S, Lewin SR, Cameron PU, 23rd Conference on Retroviruses and Opportunistic Infections (CROI), Boston, MA, 1/20/2015
• Strong functional constraint at residues in HIV-1 Gag are predicted by measures of evolutionary rather than population-level genetic conservation
  John M, Gaudieri S, Chopra A, Leary S, Jorritsma J, Mallal S, Baraki B, Brockman MA, Brumme ZL, 8th AIS Conference on HIV Pathogenesis, Treatment & Prevention, Vancouver, Canada, 1/19/2015
• HLA typing from second generation sequencing data – where are we headed?
  Cooper D, Chopra A, Blinco J, Sharma L, Dunn D, Watson M, Mallal S, Asia Pacific Histocompatibility & Immunogenetics Association Conference, Peter Doherty Institute, Melbourne, Australia, 1/15/2014
• HLA Class I-drug-T-cell receptor interactions in SJS/TEN
  Rive C, Pavlos R, Ostrov D, Plascencia P, Hung SH, Chung WH,, Peters P, Buus S, Mallal S, Phillips EJ, 6th Drug Hypersensitivity Meeting (DHM6), Bern, Switzerland, 1/9/2014
• HLA Class I-drug-T-cell receptor interactions in SJS/TEN
  Rive C, Pavlos R, Ostrov D, Plasencia P, Hung SH, Chung WH,, Peters P, Buus S, Mallal S, Phillips EJ, 6th Drug Hypersensitivity Meeting, Bern, Switzerland, 1/9/2014
• Viral adaptation in autologous viral sequences of patients with acute and early HIV infection prior to full seroconversion
  Keane NM, Almeida CA, Chopra A, Leary S, McKinnon E, Cooper D, Mallal S, John M, Australian Centre for HIV and Hepatitis Virology Research (ACH²), 10th Annual Scientific Workshop, Lorne, New South Wales, 1/4/2014
• Join now to see all

Lectures

• Putting together core technologies to your AdVANTAGE 
  Vanderbilt University, Nashville, TN - 1/30/2016
• Role of Heterologous Immunity in Transplant Rejection and Other Experiments of Man 
  Vanderbilt University, Nashville, TN - 1/30/2016
• T Cells Behaving Badly: Evolution to Population to Single Cells 
  Vanderbilt University, Nashville, TN - 1/10/2016
• Personalised approaches to Immunology 
  Perth, Western Australia - 1/20/2015
• The Flexner Discovery Lecture Series: Personalized Immunology from Bench to Bedside 
  Vanderbilt University, Nashville, TN - 1/22/2014
• Drug hypersensitivity: providing a roadmap for the investigation of heterologous immunity 
  Perth, Western Australia - 1/22/2014
• Mechanisms of drug hypersensitivity 
  Cape Town, South Africa - 1/13/2014
• Heterologous Immunity: Parallels between Transplant Rejection and Drug Hypersensitivity 
  Vanderbilt University, Nashville, TN - 1/12/2014
• Heterologous immune responses and drug hypersensitivity 
  Bern, Switzerland - 1/7/2014
• Experiments of man that shine light on enigmatic immune disease 
  Royal Perth Hospital, Perth, Western Australia - 1/7/2014
• Impact of herpes control on the immune system 
  1/1/2014
• Role of Heterologous Immune Responses in Drug Hypersensitivity, Transplant Rejection, Infection and Autoimmunity 
  Vanderbilt University, Nashville, TN - 1/15/2013
• Heterologous Immunity: a new model of drug hypersensitivity 
  Taipei, Taiwan - 1/14/2013
• Personalised Immunology 
  Vanderbilt University, Nashville, TN - 1/6/2013
• Personalized Medicine: Unmet Needs and Opportunities 
  Vanderbilt University, Nashville, TN - 1/3/2013
• Prevention of HIV in 2023: treatment as prevention, vaccines and cure. Can and will it be done? 
  Nashville, TN - 1/1/2013
• Contemporary Approaches to ART: Individualising Therapy & Avoiding Long Term Toxicity 
  Guangzhou & Shanghai, China - 1/27/2012
• A roadmap for Translating Omics to improved clinical care and fundamental scientific insights 
  Fremantle, Western Australia - 1/26/2012
• What influence when life-long treatments start? Quality of survival: seeking a way to find balance between efficiency and long term complication 
  Seoul, South Korea - 1/23/2012
• Potential role of heterologous immunity in experiments of man and nature 
  Vanderbilt University Medical Center, Nashville, TN - 1/21/2012
• Beyond Salvage Therapy 
  Kuala Lumpur, Malaysia - 1/20/2012
• Collaboration and Culture 
  Fremantle, Western Australia - 1/18/2012
• Abacavir and the altered peptide repertoire model: clinical implications 
  Glasgow, UK - 1/11/2012
• Long Term treatment considerations amongst the backbone HAART options and Making a difference in HIV patient's life 
  Taiwan - 1/2/2012
• Making a difference in HIV patient's life: What the Guidelines don't tell you 
  Taiwan - 1/2/2012
• Join now to see all

Other

• Abacavir hypersensitivity 
  Phillips E, Mallal S, UpToDate
  1/1/2008
• Monograph: Structuring therapy for successful long-term outcomes 
  
  1/1/2002
• Long-term complications: An Interactive Webcast 
  Dr H Kessler, Dr W Powderly, Dr SA Mallal
  www.hivline.com
  1/14/2000
• 7th Conference on Retroviruses and Opportunistic Infections, San Francisco, XIII International AIDS Conference, Durban 
  Monograph: Long-term complications of HIV: updates from recent international conferences
• The 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, September 13-15 2000, Toronto Canada 
  Monograph: Long-term complications of HIV: updates from recent international conferences
• The 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17-20 2000, Toronto Canada 
  Monograph: Long-term complications of HIV: updates from recent international conferences
• The 5th International Congress on Drug Therapy in HIV Infection, October 22-26 2000, Glasgow, United Kingdom 
  Monograph: Long-term complications of HIV: updates from recent international conferences
• Join now to see all